Get the Stockscreener App
77.36
1.62%
-1.27
After Hours:
77.36
Disc Medicine Inc stock is traded at $77.36, with a volume of 600.89K.
It is down -1.62% in the last 24 hours and down -17.05% over the past month.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
See More
Previous Close:
$78.63
Open:
$77.58
24h Volume:
600.89K
Relative Volume:
1.03
Market Cap:
$2.92B
Revenue:
-
Net Income/Loss:
$-91.00M
P/E Ratio:
-21.08
EPS:
-3.67
Net Cash Flow:
$-74.38M
1W Performance:
+0.61%
1M Performance:
-17.05%
6M Performance:
+41.30%
1Y Performance:
+24.69%
1-Day Range:
$76.19
$78.39
1-Week Range:
$76.19
$80.32
52-Week Range:
$30.82
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Name
Disc Medicine Inc
Sector
Industry
Phone
(617) 674-9274
Address
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
77.36 | 2.97B | 0 | -91.00M | -74.38M | -3.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Resumed | Stifel | Buy |
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jun-11-25 | Resumed | Raymond James | Strong Buy |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-04-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Oct-23-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Aug-22-24 | Initiated | Wells Fargo | Overweight |
| Apr-01-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-19-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jun-07-23 | Initiated | H.C. Wainwright | Buy |
| May-17-23 | Initiated | Raymond James | Outperform |
| Apr-28-23 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-21-23 | Initiated | Stifel | Buy |
| Apr-20-23 | Initiated | Morgan Stanley | Overweight |
| Mar-23-23 | Initiated | BMO Capital Markets | Outperform |
| Feb-28-23 | Initiated | SVB Securities | Outperform |
View All
Disc Medicine Inc Stock (IRON) Latest News
Disc Medicine (NASDAQ:IRON) Insider Sells $511,485.00 in Stock - MarketBeat
Aug Catalysts: Will Disc Medicine Inc stock deliver strong dividend growth2025 Retail Activity & Safe Entry Momentum Tips - moha.gov.vn
Disc Medicine: RALLY-MF Data Validates Pipeline Optionality (NASDAQ:IRON) - Seeking Alpha
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - ts2.tech
Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily
Disc Medicine Earnings Notes - Trefis
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com
Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда
Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada
Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com
Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
How supply chain issues affect Disc Medicine Inc. stockBond Market & Real-Time Volume Spike Alerts - DonanımHaber
Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber
Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn
Why Disc Medicine Inc. stock is seen as undervaluedJuly 2025 Momentum & Reliable Entry Point Alerts - Улправда
Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда
Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда
Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline
Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com
Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com
Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat
Insider Sell: William Savage Sells 13,093 Shares of Disc Medicine Inc (IRON) - GuruFocus
IRON Receives Updated Overweight Rating and Raised Price Target from Wells Fargo | IRON Stock News - GuruFocus
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
John Quisel Sells 40,000 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Insider Sold Shares Worth $3,721,931, According to a Recent SEC Filing - marketscreener.com
Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Inc Stock (IRON) Financials Data
Revenue
Net Income
Cash Flow
EPS
Disc Medicine Inc Stock (IRON) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khara Rahul | Chief Legal Officer |
Jan 02 '26 |
Sale |
78.69 |
6,500 |
511,472 |
37,793 |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):